NBP
NovaBridge Biosciences
NASDAQ: NBP · HEALTHCARE · BIOTECHNOLOGY
$2.35
-1.67% today
Updated 2026-04-29
Market cap
$271.77M
P/E ratio
—
P/S ratio
25.39x
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$1 – $7
Volume
0.9M
NovaBridge Biosciences (NBP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-252.16M | $-280.70M | $-867.98M | $433.56M | $-973.09M | $-1.10B | $-72.85M | $-52.65M | $-20.60M |
| Capital expenditures | $20.33M | $14.41M | $12.24M | $8.01M | $29.93M | $45.83M | $164354.00 | $48000.00 | $7000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $7.04M | $3.52M | $366.89M | $493.46M | $608.61M | $357.15M | $10.26M | $-1.95M | $5.97M |
| Free cash flow | $-272.48M | $-295.11M | $-880.22M | $425.55M | $-1.00B | $-1.15B | $-73.02M | $-52.70M | $-20.60M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $5.28M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |